Capstone Investment Advisors
GCVRZ

Capstone Investment Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Capstone Investment Advisors’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,542,395
Closed -$1.33M – 1468
2019
Q4 		$1.33M Buy
+1,542,395
New +$1.18M 0.01% 938
2014
Q4 		– Sell
-300,000
Closed -$139K – 491
2014
Q3 		$139K Hold
300,000
– – ﹤0.01% 414
2014
Q2 		$150K Hold
300,000
– – ﹤0.01% 385
2014
Q1 		$93K Hold
300,000
– – ﹤0.01% 361
2013
Q4 		$102K Sell
300,000
-215,599
-42% -$261K ﹤0.01% 469
2013
Q3 		$1.04M Sell
515,599
-114,250
-18% -$218K 0.01% 416
2013
Q2 		$1.22M Buy
+629,849
New +$1.11M 0.01% 330

Capstone Investment Advisors's GCVRZ Position: Q1 2020 in Review

Capstone Investment Advisors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 1,542,395 shares — an estimated $1.33M sold.

Capstone Investment Advisors first reported a position in GCVRZ in Q2 2013 and held it in 7 quarters. The position peaked at $1.33M in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

  • Capstone Investment Advisors reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • Capstone Investment Advisors sold 1,542,395 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $1.33M.
  • Capstone Investment Advisors first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 7 quarters.
  • Capstone Investment Advisors's Sanofi Contingent Value Rights position peaked at $1.33M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Capstone Investment Advisors's 13F filing for Q1 2020, filed 15 May 2020.